Bronchiectasis and inhaled tobramycin: A literature review

This publication has 50 references indexed in Scilit:

• Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis
  Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2013
• New developments in aminoglycoside therapy and ototoxicity
  Hearing Research, 2011
• Risk factors for aminoglycoside-associated nephrotoxicity in surgical intensive care unit patients
  International Journal of Critical Illness and Injury Science, 2011
• Efficacy of the Combination of Tobramycin and a Macrolide in an I n V itro Pseudomonas aeruginosa Mature Biofilm Model
  Antimicrobial Agents and Chemotherapy, 2010
• British Thoracic Society guideline for non-CFbronchiectasis
  Thorax, 2010
• Gentamicin-associated acute kidney injury
  QJM: An International Journal of Medicine, 2009
• Prevalence and Risk Factors for Aminoglycoside Nephrotoxicity in Intensive Care Units
  Antimicrobial Agents and Chemotherapy, 2009
• Bronchiectasis
  Chest, 2008
• The effect ofPseudomonas aeruginosaon pulmonary function in patients with bronchiectasis
  European Respiratory Journal, 2006
• Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
  New England Journal of Medicine, 1999